Skip to main content

Address And Details

Po Box 182800 , Columbus, OH 43218-2800
Fund Manager Michael Neches
Manager Tenure 8 Years 2 Months

Strategy And Objective

ProFunds Pharmaceuticals UltraSector ProFund is an open-end fund incorporated in the USA. The Fund's objective is daily investments results, before fees and expenses, that correspond to one and one-half (150%) of the performance of the DJ US Select Pharmaceuticals Index. The Fund invests at least 80% of its assets in equity securities contained in the index.

Net Asset Value

as of 6:10 PM ET 12/07/2021

Performance

  • 1 Week
  • +0.08%
  • 1 Month
  • -5.56%
  • 3 Months
  • -5.92%
  • 1 Yr Return
  • +9.71%
  • 5 Yr Return
  • +31.28%

Equity Sector Breakdown

Health 65.81%
Services 0.79%
NonDurables 0.14%
ConsumerDurables n/a
Energy n/a
Finance n/a
IndustrialCyclical n/a
RetailTrade n/a
Technology n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Stocks 78.96%
Cash 0.00%
Bonds 0.00%
Preferred 0.00%
Convertible 0.00%
Other 0.00%
ForeignStocks 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 320.00 K

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -13.19 -12.43 -5.23
Beta 1.20 1.24 1.24
R Squared 0.75 0.68 0.62
Std Deviation 25.68 23.09 20.59
Sharpe Ratio 0.42 0.39 n/a

Purchase Information

as of 6:16 PM ET 12/06/2021
Minimum Initial $15000
Minimum Additional $0
Minimum Initial IRA $0

Performance

Timeframe Average Annual Current Performance Monthly As Of 11/30/2021 Average Annual Current Performance Quarterly As Of 09/30/2021 Avg Annual Current Performance Monthly As Of 11/30/2021 Avg Annual Current Performance Quarterly As Of 09/30/2021
1 Year
  • +13.20%
  • +17.32%
+13.20% +17.32%
3 Year
  • +6.23%
  • +1.72%
+6.23% +1.72%
10 Year
  • +12.29%
  • +13.10%
+12.29% +13.10%
Life Of Fund
  • +2.02%
  • +1.91%
+2.02% +1.91%

Top 10 Holdings

Symbol Company Name % Of Assets
ZTS ZOETIS INC 3.97%
CTLT CATALENT INC 3.86%
LLY ELI LILLY & CO 3.73%
ELAN ELANCO ANIMAL HEALTH INC 3.72%
MRK MERCK & CO 3.59%
BMY BRISTOL MYERS SQUIBB CO 3.59%
VTRS VIATRIS INC 3.15%
JAZZ JAZZ PHARMACEUTICALS PLC 3.07%
OGN ORGANON & CO 2.21%
JNJ JOHNSON & JOHNSON 17.98%

LATEST NEWS

Recent Articles from TheStreet

4. Korea: Shaking with one hand

Number Of M&As Nearly Doubled In 2021: PwC

The coming years will see a combination of big and small deals across all segments

22 grizzly bear sh

Stocks Beware, BofA Says: Real Earnings Yield at 74-Year Low

There only have been four historical instances of negative real earnings yield, all of which resulted in bear markets, BofA said.

Caleres Steps Up on Second-Quarter Earnings Beat

Should You React To Quarterly Results?

Be prepared to stick to your guns if the market gets it wrong on your stocks.

Bulls vs. Bears: Cramer's 'Mad Money' Recap (Friday 2/1/19)

Cramer's Mad Money Recap 12/8: Pfizer, Sweetgreen, Edwards Lifesciences

Jim Cramer reminds us the Dow has soared from 1,000 to 35,000 over the course of his career. That's quite a run, despite all the investor negativity.

Paradise Cruise Ship Lead

Can Jimmy Buffett Take On Royal Caribbean and Carnival?

The former Bahamas Paradise cruise line will be rebranded to the singer's Margaritaville brand.

crypto

Crypto Faces Biggest Test, Morgan Stanley Says

Bitcoin headwinds as the Federal Reserve signals it is planning several rate hikes in 2022.

VanEck Bitcoin Lead

Money Managers Think Cryptocurrencies Are Due For A Correction Next Year

Don’t look for bitcoin or other digital assets to calm down anytime soon.

Wall Street Lead

Apple, Google, Jefferies Delay Workers' Return to Office

Big employers like Google and Apple are delaying plans to bring workers back to the office, but some banks are bucking that trend.

Why Consumers Aren't Shopping for Christmas Sweaters

Here's Why Supply Chain Struggles Won't Lead to a Blue Christmas for Retailers

Even major retailers including Amazon, Walmart, and Target have struggled to keep certain items in stock.

Instagram

Instagram Chief Defends Practices Amid Capitol Hill Questioning

Adam Mosseri was in front of Congress Wednesday defending his company's efforts to reduce social media's harm on youth.